The trials of translating psilocybin treatment from research to practice.
Nature Medicine August 21, 2026 DOI: 10.1038/s41591-026-04597-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Key points | Argues that translating psilocybin treatment from research to practice involves significant challenges, including regulatory, training, and protocol issues, which must be addressed to ensure safe and effective clinical use. |
Abstract
The trials of translating psilocybin treatment from research to practice.
Citations in the library
Cites 7
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology Journal of Psychopharmacology November 16, 2016
- Ethnoracial inclusion in clinical trials of psychedelics: a systematic review. EClinicalMedicine August 1, 2024
- Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials Frontiers in Psychiatry February 15, 2024
- Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder. The Journal of Clinical Psychiatry March 3, 2025
- The safety of psilocybin-assisted psychotherapy: A systematic review Australian & New Zealand Journal of Psychiatry December 13, 2024
and 2 more in the library